Lynn Minai Azary

Insider Reports History

Location
Ann Arbor, MI
Signature
/s/ Alex Levit, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lynn Minai Azary:

Company Role Class Num Shares Value Price $ Report Date Ownership
Context Therapeutics Inc. Chief Financial Officer Common Stock 80,010 $50,966 $0.6370 06 Jun 2025 Direct
Context Therapeutics Inc. Chief Financial Officer Stock Option (right to buy) 275,000 19 Feb 2026 Direct

Insider Reports Filed by Lynn Minai Azary

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CNTX Context Therapeutics Inc. 19 Feb 2026 1 $0 4 Chief Financial Officer 23 Feb 2026, 16:21
CNTX Context Therapeutics Inc. 06 Jun 2025 1 +$25,486 4 Chief Financial Officer 10 Jun 2025, 17:22
CNTX Context Therapeutics Inc. 13 Feb 2025 1 $0 4 Chief Financial Officer 14 Feb 2025, 16:13
CNTX Context Therapeutics Inc. 21 Mar 2024 1 $0 4 Chief Financial Officer 22 Mar 2024, 08:04
CNTX Context Therapeutics Inc. 13 Feb 2023 1 $0 4 Chief Financial Officer 14 Feb 2023, 16:04
CNTX Context Therapeutics Inc. 16 Dec 2022 1 +$18,500 4 Chief Financial Officer 19 Dec 2022, 15:22
CNTX Context Therapeutics Inc. 17 Aug 2022 1 +$27,000 4 Chief Financial Officer 17 Aug 2022, 17:23
CNTX Context Therapeutics Inc. 25 Feb 2022 1 $0 4 Chief Financial Officer 25 Feb 2022, 15:42
CNTX Context Therapeutics Inc. 01 Nov 2021 1 $0 4 Chief Financial Officer 01 Nov 2021, 16:31
CNTX Context Therapeutics Inc. 01 Nov 2021 0 $0 3 Chief Financial Officer 01 Nov 2021, 16:10